OSG Norwich Pharmaceuticals, a CMO based in Norwich, NY, has been acquired by AFI Partners, a NYC-based private equity group. The company, which was owned by Outsourcing Services Group, will now be known as Norwich Pharmaceuticals, Inc., and operations at the Norwich facility will continue uninterrupted, according to a company statement. In addition, the current leadership team will remain in place, and continue to manage the business. OSG Norwich launched in 2001 and its workforce has grown from 250 people to 425; all current employees will also remain with the new company.

“We are excited to begin the next chapter of our company’s history with AFI Partners,” remarked Christopher R. Calhoun, president of OSG Norwich. “Our focus will remain on providing best-in-class services to our valued customers in the pharmaceutical business. We have demonstrated that we have highly competent people who can provide the quality and service demanded by the industry, with a high level of regulatory expertise, at a value level that our customers expect. With the support of AFI, we will be able to continue to make the necessary investments in the operation to remain at the forefront of our industry.”

E. J. Antonio, managing partner at AFI, stated, “AFI brings considerable manufacturing expertise to Norwich, in addition to a shared vision for long-term growth. We are fully prepared to make the necessary investments that will expand Norwich’s capacity and capabilities. We look forward to working with the Norwich team, as we build a strategy that will maximize the company’s potential.”